Young SP - Search Results

1

How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?

Auray-Blais C, Ntwari A, Clarke JT, Warnock DG, Oliveira JP, Young SP, Millington DS, Bichet DG, Sirrs S, West ML, Casey R, Hwu WL, Keutzer JM, Zhang XK, Gagnon R. Auray-Blais C, et al. Among authors: young sp. Clin Chim Acta. 2010 Dec 14;411(23-24):1906-14. doi: 10.1016/j.cca.2010.07.038. Epub 2010 Aug 14. Clin Chim Acta. 2010. PMID: 20716442

2

Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease.

An Y, Young SP, Hillman SL, Van Hove JL, Chen YT, Millington DS. An Y, et al. Among authors: young sp. Anal Biochem. 2000 Dec 1;287(1):136-43. doi: 10.1006/abio.2000.4838. Anal Biochem. 2000. PMID: 11078593

3

Analysis of a glucose tetrasaccharide elevated in Pompe disease by stable isotope dilution-electrospray ionization tandem mass spectrometry.

Young SP, Stevens RD, An Y, Chen YT, Millington DS. Young SP, et al. Anal Biochem. 2003 May 15;316(2):175-80. doi: 10.1016/s0003-2697(03)00056-3. Anal Biochem. 2003. PMID: 12711338

4

A comparison of in vitro acylcarnitine profiling methods for the diagnosis of classical and variant short chain acyl-CoA dehydrogenase deficiency.

Young SP, Matern D, Gregersen N, Stevens RD, Bali D, Liu HM, Koeberl DD, Millington DS. Young SP, et al. Clin Chim Acta. 2003 Nov;337(1-2):103-13. doi: 10.1016/j.cccn.2003.07.006. Clin Chim Acta. 2003. PMID: 14568186

5

Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease.

An Y, Young SP, Kishnani PS, Millington DS, Amalfitano A, Corz D, Chen YT. An Y, et al. Among authors: young sp. Mol Genet Metab. 2005 Aug;85(4):247-54. doi: 10.1016/j.ymgme.2005.03.010. Mol Genet Metab. 2005. PMID: 15886040

6

Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease.

Zhang H, Kallwass H, Young SP, Carr C, Dai J, Kishnani PS, Millington DS, Keutzer J, Chen YT, Bali D. Zhang H, et al. Among authors: young sp. Genet Med. 2006 May;8(5):302-6. doi: 10.1097/01.gim.0000217781.66786.9b. Genet Med. 2006. PMID: 16702880 Free article.

7

Proposed high-risk screening protocol for Fabry disease in patients with renal and vascular disease.

Auray-Blais C, Millington DS, Young SP, Clarke JT, Schiffmann R. Auray-Blais C, et al. Among authors: young sp. J Inherit Metab Dis. 2009 Apr;32(2):303-8. doi: 10.1007/s10545-009-1055-6. Epub 2009 Jan 26. J Inherit Metab Dis. 2009. PMID: 19169844

8

A convenient LC-MS method for assessment of glucose kinetics in vivo with D-[13C6]glucose as a tracer.

Zhang H, Stevens RD, Young SP, Surwit R, Georgiades A, Boston R, Millington DS. Zhang H, et al. Among authors: young sp. Clin Chem. 2009 Mar;55(3):527-32. doi: 10.1373/clinchem.2008.113654. Epub 2009 Jan 30. Clin Chem. 2009. PMID: 19181735 Free PMC article.

9

Gb(3)/creatinine biomarkers for Fabry disease: issues to consider.

Auray-Blais C, Millington DS, Barr C, Young SP, Mills K, Clarke JT. Auray-Blais C, et al. Among authors: young sp. Mol Genet Metab. 2009 Jul;97(3):237. doi: 10.1016/j.ymgme.2009.04.006. Epub 2009 Apr 18. Mol Genet Metab. 2009. PMID: 19428279 No abstract available.

10

Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker.

Young SP, Zhang H, Corzo D, Thurberg BL, Bali D, Kishnani PS, Millington DS. Young SP, et al. Genet Med. 2009 Jul;11(7):536-41. doi: 10.1097/GIM.0b013e3181a87867. Genet Med. 2009. PMID: 19521244 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page